Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use

NCT04595084 is registered in ClinicalTrials.gov with Cambridge Health Alliance as lead sponsor.

NCT NCT04595084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04595084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use
Lead sponsor
Cambridge Health Alliance
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2021
Completion date
March 6, 2023
Enrollment
113 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use, unspecified, anxiety, covid19, depression, drug use, stress, emotional, stress, psychological, substance use